Diclofenac sodium in biliary colic: a double blind trial There is evidence that prostaglandins play a part in the pathogenesis of biliary pain.' 2 Open trials have shown that non-steroidal antiinflammatory drugs can relieve biliary pain by inhibiting the synthesis of prostaglandins. We report a double blind randomised trial of diclofenac sodium (Voltaren), a potent inhibitor of prostaglandin synthesis, versus placebo in biliary colic.
Patients, methods, and results
We studied 30 consecutive outpatients (14 men and 16 women; mean (SD) age 46 (11-8) years) with gallstone disease, confirmed by ultrasonography or radiography or at operation, who complained of biliary colic. Patients were randomly treated under double blind conditions with either 75 mg diclofenac sodium given intramuscularly or placebo and were followed up for 24 hours. All patients had given their informed consent.
Before the injection and 25 minutes afterwards patients estimated the intensity of their pain on a 100 mm analogue chromatic continuous scale on which 0 mm represented no pain and 100 mm represented unbearable pain.5
Every five minutes after the injection relief of pain was also assessed on a three point scale (1 = no relief, 2= partial relief, 3= complete relief). Patients whose pain was not relieved 25 minutes after the injection and who asked for an analgesic were treated with 75 mg diclofenac sodium intramuscularly, and relief of pain was registered using the three point scale 30 minutes later.
Fourteen patients were given diclofenac and 16 placebo. The two groups were similar for age, weight, sex, duration of pain, and initial intensity of pain according to the analogue scale. The median duration of pain before injection was three hours in the patients given diclofenac and four hours in those given placebo.
The approach. An over the needle cannula (Abbocath-T 14 gauge, 5j inches, No 4535-84) was inserted without difficulty at the midpoint of the medial border of the sternocleidomastoid muscle, lateral to the carotid artery. The cannula was used for monitoring the central venous pressure and for administering drugs during the operation. He was electively ventilated over night and extubated the following morning. From the time he began to take fluids and solids by mouth he reported difficulty in moving his tongue around his mouth, with associated trouble in mastication. Apart from this he remained clinically well. Examination showed signs of palsy of the right hypoglossal nerve with no other associated neurological deficit. In the subsequent eight weeks his tongue function improved progressively.
Comment
The hypoglossal nerve passes downwards between the internal carotid artery and the internal jugular vein, becoming superficial below the posterior belly of the digastric muscle, where it is covered by the common facial vein and deep investing fascia. After crossing the occipital artery it is held down by the lower sternomastoid branch of the occipital artery and passes forward across both internal and external carotid arteries to supply the tongue muscles. The nerve therefore lies close to the internal jugular vein and internal carotid artery at the level of the site of skin puncture used. Tethering of the hypoglossal nerve by the occipital artery or its lower sternomastoid branch is well documented,1 and anatomical variants could predispose it to trauma by percutaneous instrumentation. Reichert et al described a case of peripheral palsy of the right hypoglossal nerve after the use of a similar technique, with the difference that the cannula was passed through the sternomastoid muscle.2 They suggested that extension and rotation of the neck to facilitate puncture, and application of a pressure bandage after a failed attempt, were probable risk factors. Trauma around the carotid artery associated with carotid endarterectomy is a well known cause of injury to the nerve and is probably related to overzealous retraction.3 Agnoli and Strauss suggested that vigorous intubation during direct laryngoscopy may cause paresis of the lingual and hypoglossal nerves by a pressure effect in the parapharyngeal space. 4 Despite this rare complication of a routine procedure, which may have been due to direct trauma or haematoma around an aberrantly coursing hypoglossal nerve, we still consider high puncture of the internal jugular vein to be a useful approach.
We thank Mr F P Shabbo and Dr J E Brett for permission to report details of their patient. 
Persistence of rubella antibody 8-18 years after vaccination
Immunity induced by rubella vaccines must persist throughout the childbearing years, a period of about 30 years. We have reported persistence of rubella antibody at values exceeding 15 000 IU/l in 89 4% of volunteers vaccinated six to 16 years earlier. ' We now present the results of retesting these vaccinees two years later.
Methods and results
Serum samples were obtained between March and June 1983 from 93 of the 123 vaccinees previously tested.' Sixty three volunteers had been vaccinated with RA27/3, HPV77-DE5, Cendehill, or a Japanese vaccine To-336 eight to 10 years previously while student nurses at St Thomas's Hospital, London. Thirty volunteers had been vaccinated with either RA27/3 or Cendehill vaccine 13-18 years previously while student nurses at The Hospital for Sick Children, London. Eight of these 93 vaccinees had low antibody values (< 15 000 IU/1) when tested in 1981 and were subsequently revaccinated with RA27/3 by the intranasal route. 2 Sera were tested for rubella antibodies by single radial haemolysis3 and for rubella specific IgG by radioimmunoassay.4 Sera were compared with the standard serum containing 15 000 IU rubella antibody per 1, which is accepted as indicating a satisfactory level of immunity.3 Tests of significance were carried out using unpaired t tests.
Of the 93 vaccinees tested, two were seronegative (no zone) by single radial haemolysis (table), although both had antibodies by radioimmunoassay (titres 20 and 320). One of these women had been among the group of eight with antibody values below 15 000 IU!I who had been challenged with RA27/3 intranasally in 1981. The remaining seven had antibody values exceeding 15 000 IU/I by both single radial haemolysis and radioimmunoassay when tested two years after challenge. Eight to 10 years after vaccination the geometric mean titre of To-336 vaccinees measured by radioimmunoassay was higher than that of the other vaccine groups (table) but this difference was not significant (p > 0 05). Although volunteers given Cendehill vaccine 13-18 years previously had a lower geometric mean titre than those given the vaccine eight to 10 years before, this difference was not significant (p >0-05). The two groups of RA27/3 vaccinees had a similar geometric mean titre.
Comment
We were reassured to find that antibodies (>15 000 IU/1) had persisted in most (98%) of the rubella vaccinees eight to 18 years after vaccination. Nevertheless, in our previous study 13 of the 123 vaccinees (10-6%) had antibody values below 15 000 IU/l, even when tested by radioimmunoassay.'
Of the two women with no antibody detectable by single radial haemolysis, one, who had a radioimmunoassay titre of 20 (< 15 000 Although these results are encouraging, they should not detract from the importance of continued long term surveillance in order to determine persistence of antibody, booster antibody responses, and outcome of pregnancies among women who have been given different rubella vaccines and may have been exposed to rubella. Geometric mean titres should be interpreted with caution, since they may not merely reflect the magnitude of the immune response to vaccine but may also be a reflection of booster antibody responses due to exposure to rubella in the community. We aim to collect further blood samples from the volunteers in this study in order to test the frequency of this phenomenon.
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